Case report shows FDG PET/CT findings confirming leiomyosarcoma in a man after prostate adenocarcinoma, suggesting its diagnostic value in rare sarcomas.
The prostatic sarcomas are exceedingly rare, constituting less than 0.1% of all primary prostate neoplasms. Although the importance of Ga-68 prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in prostate adenocarcinoma is well established, it is not useful in prostate sarcomas. Herein, we present fluorodeoxyglucose (18F-FDG) PET/CT findings of an 81-year-old man with a prostatic mass, which confirmed the diagnosis of leiomyosarcoma.
No takes yet. Share an insight, caveat, or question.
Öksüzoğlu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: